Source: Cancers. Unidades: FM, FMRP
Subjects: ANOREXIA, CAQUEXIA, NEOPLASIAS, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Olga Laura Sena et al. Mirtazapine versus megestrol in the treatment of anorexia–cachexia syndrome in patients with advanced cancer: a randomized, double-blind, controlled phase II clinical trial. Cancers, v. 15, n. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15143588. Acesso em: 08 out. 2025.APA
Almeida, O. L. S., Ferriolli, E., Taveira, R. C. C., Rosenburg, M. G., Campanari, D. D., Alves, N. M. da C., et al. (2023). Mirtazapine versus megestrol in the treatment of anorexia–cachexia syndrome in patients with advanced cancer: a randomized, double-blind, controlled phase II clinical trial. Cancers, 15( 14), 1-14. doi:10.3390/cancers15143588NLM
Almeida OLS, Ferriolli E, Taveira RCC, Rosenburg MG, Campanari DD, Alves NM da C, Pfrimer K, Rapatoni L, Peria FM, Lima NK da C. Mirtazapine versus megestrol in the treatment of anorexia–cachexia syndrome in patients with advanced cancer: a randomized, double-blind, controlled phase II clinical trial [Internet]. Cancers. 2023 ; 15( 14): 1-14.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/cancers15143588Vancouver
Almeida OLS, Ferriolli E, Taveira RCC, Rosenburg MG, Campanari DD, Alves NM da C, Pfrimer K, Rapatoni L, Peria FM, Lima NK da C. Mirtazapine versus megestrol in the treatment of anorexia–cachexia syndrome in patients with advanced cancer: a randomized, double-blind, controlled phase II clinical trial [Internet]. Cancers. 2023 ; 15( 14): 1-14.[citado 2025 out. 08 ] Available from: https://doi.org/10.3390/cancers15143588